About Thierry Porte
Form D filings for Acta Pharmaceuticals in 2024 list Thierry Porte as director.
Thierry Porte first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Thierry Porte in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thierry Porte works with at each company, as listed on that company's latest Form D.
Acta Pharmaceuticals, Inc. · Form D/A, Apr 22, 2024
GA
George Alex
President and director
RT
Rudolph Tanzi
Director